Guardant Health Statistics
Total Valuation
Guardant Health has a market cap or net worth of $5.16 billion. The enterprise value is $5.77 billion.
Important Dates
The last earnings date was Wednesday, April 30, 2025, after market close.
| Earnings Date | Apr 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Guardant Health has 123.89 million shares outstanding. The number of shares has increased by 5.60% in one year.
| Current Share Class | 123.89M |
| Shares Outstanding | 123.89M |
| Shares Change (YoY) | +5.60% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 4.27% |
| Owned by Institutions (%) | 91.91% |
| Float | 112.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.64 |
| Forward PS | 5.59 |
| PB Ratio | -20.58 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.45 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.11
| Current Ratio | 4.11 |
| Quick Ratio | 3.61 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -166.70 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -18.64% |
| Return on Invested Capital (ROIC) | -22.99% |
| Return on Capital Employed (ROCE) | -40.64% |
| Revenue Per Employee | $382,977 |
| Profits Per Employee | -$206,109 |
| Employee Count | 2,021 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 4.27 |
Taxes
In the past 12 months, Guardant Health has paid $1.17 million in taxes.
| Income Tax | 1.17M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +86.23% in the last 52 weeks. The beta is 1.49, so Guardant Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.49 |
| 52-Week Price Change | +86.23% |
| 50-Day Moving Average | 43.63 |
| 200-Day Moving Average | 34.82 |
| Relative Strength Index (RSI) | 43.66 |
| Average Volume (20 Days) | 2,728,000 |
Short Selling Information
The latest short interest is 7.71 million, so 6.22% of the outstanding shares have been sold short.
| Short Interest | 7.71M |
| Short Previous Month | 7.62M |
| Short % of Shares Out | 6.22% |
| Short % of Float | 6.87% |
| Short Ratio (days to cover) | 3.83 |
Income Statement
In the last 12 months, Guardant Health had revenue of $774.00 million and -$416.55 million in losses. Loss per share was -$3.38.
| Revenue | 774.00M |
| Gross Profit | 474.77M |
| Operating Income | -454.58M |
| Pretax Income | -490.27M |
| Net Income | -416.55M |
| EBITDA | -412.67M |
| EBIT | -454.58M |
| Loss Per Share | -$3.38 |
Full Income StatementBalance Sheet
The company has $698.57 million in cash and $1.31 billion in debt, giving a net cash position of -$607.81 million or -$4.91 per share.
| Cash & Cash Equivalents | 698.57M |
| Total Debt | 1.31B |
| Net Cash | -607.81M |
| Net Cash Per Share | -$4.91 |
| Equity (Book Value) | -250.79M |
| Book Value Per Share | -2.03 |
| Working Capital | 701.27M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$272.26 million and capital expenditures -$32.61 million, giving a free cash flow of -$304.87 million.
| Operating Cash Flow | -272.26M |
| Capital Expenditures | -32.61M |
| Free Cash Flow | -304.87M |
| FCF Per Share | -$2.46 |
Full Cash Flow StatementMargins
Gross margin is 61.34%, with operating and profit margins of -58.73% and -53.82%.
| Gross Margin | 61.34% |
| Operating Margin | -58.73% |
| Pretax Margin | -53.67% |
| Profit Margin | -53.82% |
| EBITDA Margin | -53.32% |
| EBIT Margin | -58.73% |
| FCF Margin | n/a |
Dividends & Yields
Guardant Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.60% |
| Shareholder Yield | -5.60% |
| Earnings Yield | -8.07% |
| FCF Yield | -5.91% |
Dividend DetailsAnalyst Forecast
The average price target for Guardant Health is $52.81, which is 26.76% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $52.81 |
| Price Target Difference | 26.76% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 21 |
| Revenue Growth Forecast (5Y) | 19.74% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Guardant Health has an Altman Z-Score of -1.28 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.28 |
| Piotroski F-Score | 4 |